ConductScience.org, home

Paper41004020

Exploring the Activity of Bacteriocins Against Bacterial Biofilms Using a Simple and Inexpensive Assay.

Fernández M and 6 others. Probiotics Antimicrob Proteins, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Exploring the Activity of Bacteriocins Against Bacterial Biofilms Using a Simple and Inexpensive Assay. Papers, record 41004020. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41004020

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Exploring the Activity of Bacteriocins Against Bacterial Biofilms Using a Simple and Inexpensive Assay.
PubMed
Journal
Probiotics Antimicrob Proteins
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-03
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fernández MMatilde
2Torices MIMaría Isabel
3Teso CClaudia
4Moreno CCarlos
5Maqueda MMercedes
6Valdivia EEva
7Montalbán-López MManuel

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BiofilmsMajor topic
BacteriocinsMajor topic
Anti-Bacterial AgentsMajor topic
Gram-Positive BacteriaMajor topic
Gram-Negative BacteriaMajor topic
Microbial Sensitivity Tests
Nisin

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P20_00339Proyectos de I+D+i del Plan Andaluz de Investigación, Desarrollo e InnovaciónPubMed
B-BIO-268-UGR20Programa Operativo FEDER 2020PubMed
C-EXP-163-UGR23Programa Operativo FEDER 2021-2027PubMed

Source PubMed

Download CSV of grants

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116973881An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.Science2006https://conductscience.org/library/papers/16973881PubMed
238730101Bacteriocin diversity, function, discovery and application as antimicrobials.Nat Rev Microbiol2024https://conductscience.org/library/papers/38730101PubMed
324025153
Limitations of MIC as the sole criterion in antimicrobial drug dosage regimen design: the need for full characterization of antimicrobial pharmacodynamic profile especially for drug-resistant organisms.
Vet J2013https://conductscience.org/library/papers/24025153PubMed
414607403A simple method for semi-preparative-scale production and recovery of enterocin AS-48 derived from Enterococcus faecalis subsp. liquefaciens A-48-32.J Microbiol Methods2003https://conductscience.org/library/papers/14607403PubMed
536879323Customized biofilm device for antibiofilm and antibacterial screening of newly developed nanostructured silver and zinc coatings.J Biol Eng2023https://conductscience.org/library/papers/36879323PubMed
619291402Modeling growth and quorum sensing in biofilms grown in microfluidic chambers.Ann Biomed Eng2009https://conductscience.org/library/papers/19291402PubMed
733006097Bacteriocin-a potential antimicrobial peptide towards disrupting and preventing biofilm formation in the clinical and environmental locales.Environ Sci Pollut Res Int2020https://conductscience.org/library/papers/33006097PubMed
834419547Antibacterial directed chemotherapy using AS-48 peptide immobilized on biomimetic magnetic nanoparticles combined with magnetic hyperthermia.Int J Biol Macromol2021https://conductscience.org/library/papers/34419547PubMed
921590312AS-48 bacteriocin: close to perfection.Cell Mol Life Sci2011https://conductscience.org/library/papers/21590312PubMed
1035115704Tolerance and resistance of microbial biofilms.Nat Rev Microbiol2022https://conductscience.org/library/papers/35115704PubMed
1122212072Pseudomonas biofilm matrix composition and niche biology.FEMS Microbiol Rev2012https://conductscience.org/library/papers/22212072PubMed
1218274517Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances.Nat Protoc2008https://conductscience.org/library/papers/18274517PubMed
1311168186EUCAST Definitive Document E.Def 1.2, May 2000: Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents.Clin Microbiol Infect2000https://conductscience.org/library/papers/11168186PubMed
1420457816Spatial and temporal patterns of biocide action against Staphylococcus epidermidis biofilms.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20457816PubMed
1523558192Combined treatments of enterocin AS-48 with biocides to improve the inactivation of methicillin-sensitive and methicillin-resistant Staphylococcus aureus planktonic and sessile cells.Int J Food Microbiol2013https://conductscience.org/library/papers/23558192PubMed
1631088602Nisin penetration and efficacy against Staphylococcus aureus biofilms under continuous-flow conditions.Microbiology (Reading)2019https://conductscience.org/library/papers/31088602PubMed
1723070152In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/23070152PubMed
1834438974Antimicrobial Activity of the Circular Bacteriocin AS-48 against Clinical Multidrug-Resistant Staphylococcus aureus.Antibiotics (Basel)2021https://conductscience.org/library/papers/34438974PubMed
1917218029A new device for rapid evaluation of biofilm formation potential by bacteria.J Microbiol Methods2007https://conductscience.org/library/papers/17218029PubMed
2036819031Advances in the preclinical characterization of the antimicrobial peptide AS-48.Front Microbiol2023https://conductscience.org/library/papers/36819031PubMed

See all 58 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41004020

GET https://conductscience.org/api/papers/v1/41004020/references?page=2